Anpario (LON:ANP) Releases Quarterly Earnings Results

Anpario (LON:ANP) announced its earnings results on Wednesday. The company reported GBX 22.45 earnings per share for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 16.88% and a net margin of 14.31%.

Anpario Price Performance

Shares of ANP stock traded down GBX 12.12 during midday trading on Thursday, reaching GBX 467.88. 65,989 shares of the company traded hands, compared to its average volume of 45,537. The firm’s 50 day simple moving average is GBX 531.50 and its two-hundred day simple moving average is GBX 516.75. The firm has a market cap of £76.20 million, a PE ratio of 12.33 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a current ratio of 4.50 and a quick ratio of 5.16. Anpario has a 1-year low of GBX 391.11 and a 1-year high of GBX 580.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ANP shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 570 price target on shares of Anpario in a report on Friday, June 26th. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research note on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.